期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Recent progress in the use of periplocin,periplocymarin and periplogenin in cancer treatment
1
作者 Xin Sun Xiao-Wei Shi +3 位作者 Lei Han Yi-Fan Zhang Yang Xu Yu-Cheng Lu 《World Journal of Clinical Oncology》 2025年第8期48-57,共10页
Periplocin,periplocymarin and periplogenin are the main active components of Cortex Periplocae.The most cytotoxic constituent of Cortex Periplocae,periplocin is an alpha cardiac glycoside with a steroid core and an un... Periplocin,periplocymarin and periplogenin are the main active components of Cortex Periplocae.The most cytotoxic constituent of Cortex Periplocae,periplocin is an alpha cardiac glycoside with a steroid core and an unsaturated five-membered lactone ring structure.Periplocymarin is a secondary alpha cardiac glycoside,which is produced by removing one molecule of glucose from periplocin,and periplogenin is the glycosidic portion and the basic unit of periplocin and periplocymarin.These three cardiac glycosides,by virtue of their unique pharmacological activities and mechanisms of action,mediate signaling pathways,mainly the retinoblastoma and p53 signaling pathways,and regulate cell cycle proteins,thereby hindering the proliferation of cancer cells and altering the cell cycle process.These glycosides also regulate caspase proteins by mediating endogenous and exogenous pathways,thereby inducing the apoptosis of cancer cells.This minireview focuses on the inhibitory effects of periplocin,periplocymarin and periplogenin on cancer,and explores their potential antitumor mechanisms. 展开更多
关键词 PERIPLOCIN Periplocymarin Periplogenin Cancer therapy cortex periplocae
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部